Wolverine Asset Management’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,715
Closed -$5.33K 1703
2024
Q1
$5.33K Buy
+1,715
New +$5.77K ﹤0.01% 1383
2023
Q3
Sell
-1,132
Closed -$3.24K 1914
2023
Q2
$3.24K Sell
1,132
-1,396
-55% -$5.03K ﹤0.01% 1531
2023
Q1
$7.81K Sell
2,528
-2,594
-51% -$7.38K ﹤0.01% 1478
2022
Q4
$10.8K Sell
5,122
-4,548
-47% -$13.8K ﹤0.01% 1613
2022
Q3
$31K Sell
9,670
-1,000
-9% -$3.83K ﹤0.01% 1714
2022
Q2
$34K Sell
10,670
-543
-5% -$3.02K ﹤0.01% 1685
2022
Q1
$79K Sell
11,213
-1,937
-15% -$11.3K ﹤0.01% 1377
2021
Q4
$95K Buy
+13,150
New +$130K ﹤0.01% 1373
2021
Q3
Sell
-55,503
Closed -$565K 2144
2021
Q2
$565K Buy
55,503
+50,289
+964% +$518K ﹤0.01% 851
2021
Q1
$56K Sell
5,214
-101,156
-95% -$1.1M ﹤0.01% 1602
2020
Q4
$1.08M Buy
+106,370
New +$1.05M 0.01% 626

Other funds holding HUMA

Wolverine Asset Management's HUMA Position: Q2 2024 in Review

Wolverine Asset Management sold out of Humacyte (HUMA) in Q2 2024, closing a stake of 1,715 shares — an estimated $5.33K sold.

Wolverine Asset Management first reported a position in HUMA in Q4 2020 and held it in 11 quarters. The position peaked at $1.08M in Q4 2020. 123 funds tracked by Wall St. Rank hold HUMA as of Q2 2024.

  • Wolverine Asset Management reported no remaining Humacyte position as of Q2 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 1,715 Humacyte shares in Q2 2024, an estimated $5.33K.
  • Wolverine Asset Management first reported a position in Humacyte in Q4 2020 and held it in 11 quarters.
  • Wolverine Asset Management's Humacyte position peaked at $1.08M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Humacyte as of Q2 2024.

Based on Wolverine Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.